Laboratory instruments maker, Thermo Fisher Scientific, is planning to sell two lab-testing divisions, Bloomberg reports. The $1 billion sale is part of the Massachusetts-based company’s strategy to focus on equipment rather than services. The company has appointed Goldman Sachs to manage the Athena Diagnostics unit sale, which may fetch about $600-700 million. Barclays Capital has been hired to handle the sale of the Lancaster Labs, which may collect around $200-300 million.
Click here for the story from Bloomberg.